batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
CTP-MCVF-006
Phase 3 mab active
Quick answer
batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4) for Meningococcal Meningitis is a Phase 3 program (mab) at CanSino Biologics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CanSino Biologics
- Indication
- Meningococcal Meningitis
- Phase
- Phase 3
- Modality
- mab
- Status
- active